Combined angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) therapy is safe and effective in kidney transplant patients

被引：0
|
作者：
Reilly, James B. [1 ]
Goral, Simin [1 ]
Bloom, Roy D. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [1] Effect of Angiotensin Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blockade (ARB) Exposure on Intragraft Gene Expression of Kidney Transplant Patients
    Suarez-Fuentes, C.
    Broin, O.
    Bao, Y.
    Akalin, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 323 - 324
  • [2] Combined treatment of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker in kidney transplant recipients with persistent proteinuria
    Tuncer, M
    Kocak, H
    Yavuz, A
    Karatas, GU
    Erdogan, O
    Gurkan, A
    Dinckan, A
    Ersoy, F
    Yakupoglu, G
    Demirbas, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V15 - V15
  • [3] Diuretics are necessary for optimal renoprotection of angiotensin-converting enzyme (ACEI) or Angiotensin II receptor blocker (ARB).
    Nakao, NN
    Yoshimura, A
    Morita, H
    Inui, K
    Ideura, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 243A - 243A
  • [4] THE EFFECT OF COMBINED ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE-I) AND ANGIOTENSIN II RECEPTOR BLOCKER (ARB) ON ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Yang, W. S.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A140
  • [5] Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) Use are Associated With Increased Readmission After Ileostomy Creation
    Gan, Connie Y.
    Rahman, Shahrose
    Flerchinger, Shaun R.
    Barton, Jeffrey S.
    AMERICAN SURGEON, 2025, 91 (04) : 556 - 560
  • [6] Angiotensin Converting Enzyme Inhibitor (ACEI)/Angiotensin II Receptor Blockers (ARB) and Pneumonia Risk among Stroke Patients
    Liu, Chia-Lin
    Shau, Wen-Yi
    Wu, Chi-Shin
    Lai, Mei-Shu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S80 - S80
  • [7] Markov Modeling for Microvascular Renal Complication of NIDDM and Hypertension to Evaluate the Use of Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB)
    Hidayat, Y. A.
    Padmasawitri, T. I. A.
    Sigit, J. I.
    WORLD CONGRESS ON ENGINEERING - WCE 2013, VOL I, 2013, : 59 - +
  • [8] Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy
    Yang, Y
    Ohta, K
    Shimizu, M
    Nakai, A
    Kasahara, Y
    Yachie, A
    Koizumi, S
    CLINICAL NEPHROLOGY, 2005, 64 (01) : 35 - 40
  • [9] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [10] Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy - Response
    Ohta, K
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 227 - 228
12345